Flagship Pioneering provides $50 mln to Foghorn Therapeutics
Cambridge, Massachusetts-based Foghorn Therapeutics, a developer of therapies for cancer and other serious diseases, has secured $50 million in funding. The investor was Flagship Pioneering.
14 March 2018•1 min read
